GSK
741 hedge funds and large institutions have $9.53B invested in GSK in 2016 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 283 increasing their positions, 259 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 283 | Existing positions reduced: 259
0.23% more ownership
Funds ownership: 3.39% → 3.61% (+0.23%)
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
Holders
741
Holding in Top 10
10
Calls
$179M
Puts
$127M
Top Buyers
| 1 | +$210M | |
| 2 | +$206M | |
| 3 | +$163M | |
| 4 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$68.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$44M |
Top Sellers
| 1 | -$160M | |
| 2 | -$75.2M | |
| 3 | -$67.9M | |
| 4 |
Millennium Management
New York
|
-$28.9M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$20.6M |